The funding aims to support the company’s growth as it works to make emergency healthcare more affordable and accessible.

Impulse Biomedical was founded by Giancarlo Beukes and Gokul Nair, both of whom have backgrounds in engineering.

The company is focused on creating innovative medical devices that improve emergency treatment and patient care.

Two of its key products include the Easy Squeezy—a cost-effective and easy-to-use asthma inhaler—and the ZiBiPen, a refillable epinephrine auto-injector designed to offer a more sustainable and budget-friendly option compared to disposable ones.

Giancarlo Beukes expressed confidence about the future of the startup following the investment:

“This collaboration is a major step toward making life-saving healthcare tools more available on a global scale. We’re aligned with E Squared in our vision of driving progress and making a real impact,” he said.

Pyi Maung, head of investments at E Squared Investments, said the decision to support Impulse Biomedical was based on its strong mission and potential to deliver social good.

“We invest in ventures that combine business success with positive social outcomes. Impulse Biomedical reflects the kind of innovation and commitment needed in South Africa and beyond,” Maung noted.

With this new partnership, Impulse Biomedical is positioned to expand its reach and continue developing practical solutions for healthcare systems facing cost and access challenges.